Retrospective Evaluation of Clinical & Radiographic Outcomes Following

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study is a retrospective analysis of patients who underwent surgery using a total talus replacement (TTR) implant with or without concurrent total ankle replacement and/or subtalar fusion. This study seeks to analyze the clinical and radiographic outcomes of TTR implant recipients and generate additional data on the safety and benefit of the TTR implant.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03674905` - Peripheral Nerve Block Compared to Intra-articular Injection for TAA Post-operative Pain	N/A
Active, not recruiting	`NCT05170321` - Analysis of Influencing Factors and Construction of Prediction Models of Artificial Joint Replacement in China
Withdrawn	`NCT04022057` - The Impact of a Preoperative Nerve Block in Foot and Ankle Surgery on the Consumption of Sevoflurane	Phase 2/Phase 3

NCT number	NCT05231304
Study type	Observational
Source	Restor3D
Contact
Status	Completed
Phase
Start date	April 5, 2022
Completion date	February 19, 2024

Retrospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement — RECLAIM

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms